Corrigendum to “The controversies in the clinical management of β-blockers in acute heart failure induced by rapid atrial fibrillation: A narrative review” AHJO₁00655
This research addresses the conflicting opinions surrounding the efficacy of β-blockers in managing acute heart failure caused by rapid atrial fibrillation.
Reviewed existing literature on the use of β-blockers in acute heart failure.
Analyzed various clinical guidelines and recommendations.
Identified controversies and gaps in current management practices.
Highlight significant variations in clinical practices regarding β-blocker usage.
Point out concerns related to patient outcomes and medication efficacy.
Suggest areas needing further investigation for guideline development.
Abstract
This corrects the article DOI: 10.1016/j.ahjo.2025.100655..